Literature DB >> 9466544

Identification and characterization of herpes simplex virus-specific CD4+ T cells in corneas of herpetic stromal keratitis patients.

G M Verjans1, L Remeijer, R S van Binnendijk, J G Cornelissen, H J Völker-Dieben, S G Baarsma, A D Osterhaus.   

Abstract

Herpetic stromal keratitis (HSK) is a corneal disease initiated by a herpes simplex virus (HSV) infection with a postulated T cell-mediated immunopathology. To study the antigen specificity of cornea-infiltrating T cells in HSK patients, T cells were isolated and expanded by mitogenic stimulation from corneas of 2 patients with HSV-1-mediated HSK. A substantial number of the T cell clones (TCCs) obtained from these T cell lines were HSV-specific. All HSV-specific TCCs were of the CD3+CD4+CD8- phenotype. These TCCs responded to autologous HSV-infected corneal keratocytes, which expressed HLA class II molecules following incubation with interferon-gamma. Upon HSV-specific stimulation, all TCCs secreted interleukin-4, interleukin-5, and interferon-gamma. The data presented suggest that HSV-specific CD4+ T cells play a role in the immunopathogenesis of HSK in humans and that corneal keratocytes may act as antigen-presenting cells in this local T cell response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466544     DOI: 10.1086/517382

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion protein.

Authors:  A H Brandenburg; L de Waal; H H Timmerman; P Hoogerhout; R L de Swart; A D Osterhaus
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 2.  Herpesvirus Entry Mediator and Ocular Herpesvirus Infection: More than Meets the Eye.

Authors:  Rebecca G Edwards; Richard Longnecker
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

3.  Immunodominant "asymptomatic" herpes simplex virus 1 and 2 protein antigens identified by probing whole-ORFome microarrays with serum antibodies from seropositive asymptomatic versus symptomatic individuals.

Authors:  Gargi Dasgupta; Aziz A Chentoufi; Mina Kalantari; Payam Falatoonzadeh; Sookhee Chun; Chang Hyun Lim; Philip L Felgner; D Huw Davies; Lbachir BenMohamed
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

4.  Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.

Authors:  Lichen Jing; Jürgen Haas; Tiana M Chong; Joseph J Bruckner; Greg C Dann; Lichun Dong; Joshua O Marshak; Christopher L McClurkan; Tori N Yamamoto; Susanne M Bailer; Kerry J Laing; Anna Wald; Georges M G M Verjans; David M Koelle
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

5.  Herpes simplex virus type 1 DNA is immunostimulatory in vitro and in vivo.

Authors:  Patric Lundberg; Paula Welander; Xiao Han; Edouard Cantin
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Production of the Cytokine VEGF-A by CD4+ T and Myeloid Cells Disrupts the Corneal Nerve Landscape and Promotes Herpes Stromal Keratitis.

Authors:  Hongmin Yun; Michael B Yee; Kira L Lathrop; Paul R Kinchington; Robert L Hendricks; Anthony J St Leger
Journal:  Immunity       Date:  2020-11-17       Impact factor: 31.745

7.  CD154 signaling regulates the Th1 response to herpes simplex virus-1 and inflammation in infected corneas.

Authors:  Min Xu; Andrew J Lepisto; Robert L Hendricks
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

8.  Topical antisense-oligonucleotides targeting IFN-gamma mRNA improve incidence and severity of herpetic stromal keratitis by cytokine specific and sequence unspecific effects.

Authors:  Susanne Wasmuth; Dirk Bauer; Klaus-Peter Steuhl; Arnd Heiligenhaus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-11-21       Impact factor: 3.117

9.  Immunization with a replication-defective herpes simplex virus 2 mutant reduces herpes simplex virus 1 infection and prevents ocular disease.

Authors:  Allison L van Lint; Ernesto Torres-Lopez; David M Knipe
Journal:  Virology       Date:  2007-10-29       Impact factor: 3.616

10.  Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis.

Authors:  Cristina P Marques; Maxim C-J Cheeran; Joseph M Palmquist; Shuxian Hu; Stina L Urban; James R Lokensgard
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.